Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.26 - $0.87 $19,200 - $64,246
-73,847 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$0.6 - $1.82 $24,019 - $72,858
40,032 Added 118.39%
73,847 $63,000
Q4 2021

Feb 14, 2022

BUY
$1.53 - $3.12 $33,376 - $68,062
21,815 Added 181.79%
33,815 $52,000
Q3 2021

Nov 15, 2021

SELL
$2.69 - $4.94 $137,190 - $251,940
-51,000 Reduced 80.95%
12,000 $37,000
Q2 2021

Aug 16, 2021

BUY
$4.81 - $10.34 $303,030 - $651,420
63,000 New
63,000 $303,000

Others Institutions Holding KRBP

About Kiromic Biopharma, Inc.


  • Ticker KRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,843,200
  • Market Cap $15.8M
  • Description
  • Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...
More about KRBP
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.